Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (PIN4) is a member of the parvulin subfamily of peptidyl-prolyl cis-trans isomerases (PPIases), enzymes that catalyze the isomerization of peptide bonds at prolyl residues, thereby regulating protein folding and function[1][2][5]. The human PIN4 gene encodes two main isoforms through alternative transcription: Par14 and Par17. Par14 is primarily involved in ribosomal RNA processing, chromatin remodeling, and ribosome biogenesis, while Par17 contains an amphipathic N-terminal helix and shares some DNA-binding and regulatory activities[2][1]. PIN4 may also participate in mitochondrial function and microtubule polymerization[1][2]. It is implicated in several diseases including prostate cancer and hepatocellular carcinoma, partly through its roles in the cell cycle and interaction with viral proteins. It significantly supports hepatitis B virus replication by stabilizing viral core particles and regulating transcription. PIN4 is a validated enzyme target, and small-molecule inhibitors such as juglone and other parvulin impeders are being explored for potential therapeutic applications, particularly in cancer and viral diseases[2].
Inhibition of cis/trans isomerase activity, leading to impaired protein folding and decreased cell proliferation[2]. Disruption of HBV replication by interfering with PIN4’s stabilization and function in viral lifecycles[2].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (PIN4).